WHO ARE WE
Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of
The company’s patent-pending, porous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of
macromolecules (such as monoclonal antibodies) or small molecules (such as ibuprofen) for fast and sustained delivery.
We pride ourselves on providing a painless experience for all of those involved in the production, delivery, and consumption of medicines.
At Anodyne Nanotech, we believe that the delivery of necessary medication should not and will not be a painful process. For anyone involved. For hundreds of years, needles and syringes have been used to deliver medicine, and innovation is long overdue.
The Hero Patch is the first platform capable of efficiently delivering large enough quantities of medicine to begin replacing antiquated and cumbersome injections.
Together, we will redefine drug delivery.
CO-FOUNDER AND CEO
CO-FOUNDER AND CBO
CO-FOUNDER AND CTO
Jake has a unique combination of biomedical engineering experience and entrepreneurial acumen. He holds a B.S. of Biomedical Engineering from Union College and an M.Sc. of Innovation and Management from Tufts University. He couples this with leadership qualities developed over a lifetime of team sports to help set the direction of Anodyne.
Konstantinos is an engineer turned entrepreneur. He holds a Diploma in Electrical and Computer Engineering from National Technical University of Athens and an M.Sc. in Innovation and Management from Tufts University, Boston, USA. Konstantinos has engineering and management expertise coupled with exposure in the US and Greece, making the alignment of interdisciplinary teams second nature.